Giuseppe RemuzziMaria Grazia FranzosiMarco DorigoRaffaella GiavazziChiara CerlettiAnna RobertoClaudio Marcello MarzoElena RicciCaterina BendottiFrancesco BertoniCinzia ColomboLetizia PolitoMassimo ZucchettiMaurizio D'IncalciEmma Gracia LorRosanna PiccirilloValentina MilaniCarmen GhilardiFrancesca BraviEzia BelloAndrea RemuzziMarco GobbiNicola PortaCarlotta RossiStefano FinazziAlessandra LugoSilvano GallusAnna LombardoDiego BadernaEttore BeghiJacopo LucchettiGiorgia GiussaniMatias TrilliniGiovanna D'AmicoLavinia MorosiEnrico DavoliFrancesco RivaLital HollanderAlessandro FantinEdoardo Parrella
P108
CoQun Study - (COQUN): a Study to Evaluate the Effects of CoQun in Patients Affected by Open-angle GlaucomaAtezolizumab Trial in Endometrial Cancer - AtTEndMMF vs. AZA for Kidney TransplantationPreventing ESRD in Overt Nephropathy of Type 2 DiabetesSirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and SafetyAn Efficacy Study Of Ortataxel In Recurrent GlioblastomaITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)Sevelamer in Proteinuric CKDPreventing Microalbuminuria in Type 2 DiabetesLow vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)Tolvaptan-Octreotide LAR Combination in ADPKDReal Time Amplitude Spectrum Area to Guide DefibrillationInsulin Treatment in Diabetic Older People With Heart Failure.Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-OlaparibProphylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.NASCITA Italian Birth Cohort Study: a Study ProtocolNon-contrast Enhanced MRI in Patients With C3 Glomerulopathy (C3G) or Immune-complex Membranoproliferative Glomerulonephritis (IC-MPGN) Enrolled in the ACH471-205 StudyPeripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes.Treat_CCM: Propranolol in Cerebral Cavernous Malformation
P859
Q16561003-be493e5b-4379-22ab-8a09-3e82aa9bf6a6Q30093334-1996926d-4fb8-2998-e93d-ef5b12a415d5Q3290091-6C9F6F2A-E6F6-489B-93BA-F46744F4D36DQ37381116-0BE1CF3A-B7D3-4718-A380-82FF6B1380AEQ37834348-748B30C2-4186-4662-AA5B-21405EC14C01Q38800330-799F540D-8D29-4C15-9F20-1A7F5997932FQ38804435-4A035384-15E3-45B0-917E-25F0755ABA9AQ39061524-7A9BC340-266A-4C45-9513-EFE0DC7C7696Q39188656-7A03E6C3-F6B5-4331-9022-9D6B10429DB0Q40033742-47887305-F2BB-4F8C-9C84-4DB7304302C6Q42706203-A4C21A77-A4C6-4643-A836-DD2EB8C44ABEQ42872905-C2B8A735-5201-447E-B889-3BCD991B187EQ42872905-C4481A35-46CB-46E1-952C-1194ADBDEB52Q42875997-6DA66651-5DA9-4B2C-A0A9-2D126E2A41C1Q42876004-2046029F-FC1F-4933-B23D-8BB52C552727Q42876004-61348C13-188C-4BA5-9FFB-A603AE3D5FEEQ42876004-6409AD19-5121-4BBD-A2EB-C61D029D3E50Q42876004-9C8C9411-64B0-474E-AF86-66E6BAEBE898Q42876004-E1BF26BC-DFAD-497E-BB7D-0E185DD7144AQ42876004-E5003D58-C78A-48E0-8B2D-AC76B0A5E705Q42889788-01B6C9F8-265B-47A0-8EC8-E0FF101C0527Q42906546-46C25FB1-2474-45AA-A22D-E805F4BD30C8Q42943970-E0CF440E-4873-474C-A030-B3BBD3F339B3Q42946278-74D2B7DC-1B19-478C-8D6F-8F37D8CEE821Q43131200-53A85A8E-4536-4F3D-96D6-87164D3FF9B9Q43131200-561CA245-1D79-4CB4-B9B2-481936FDBBBDQ43223594-14DFDDCA-71C1-45CA-A0AD-6EDB07DF9825Q43292863-66800F88-5D05-4CCF-ABDC-10C20A154652Q45281186-631A1F7C-A6F8-4A38-BE73-6FB964AE4DEBQ45340079-10EA3A3D-5DC3-42A6-B944-4BCE489A728AQ45348356-575D4E58-504F-4A87-A3D9-FE3E2F4BD045Q45348366-007B856B-3063-4A74-8547-54BC0F5E4840Q45898614-5B055E2A-22FD-45E7-A1CA-7204F52B3AF4Q45898624-B3CBBBBE-30D6-45D1-BCFC-5C02BEF74CA6Q45918980-EAC4F09B-25A4-42AD-8656-D70A212BB8A9Q46948287-7011122E-FAAF-41E9-A907-048DD37BF342Q46948287-95991C8C-3282-48D8-85BE-E94E98DBE3F9Q46948287-D361F2DC-82DA-4CD6-897C-3E8C275C6461Q47264144-7A03F52D-F394-42E9-9BCA-1B0953335AA3Q47503767-2F7CA480-402F-42A4-B682-8D96075C24EC
P108
description
italienische Organisation
@de
nonprofit research institute in Italy
@en
organisaatio
@fi
organisatie uit Italië
@nl
organizatë
@sq
منظمة في ميلانو، إيطاليا
@ar
意大利研究机构
@zh
意大利研究机构
@zh-hans
name
Istituto di ricerche farmacologiche "Mario Negri"
@it
Mario Negri Institute for Pharmacological Research
@en
Mario Negri Institute for Pharmacological Research
@fr
Mario Negri Institute for Pharmacological Research
@nl
馬里奧內格里藥理研究所
@zh-hant
马里奥·内格里药理研究所
@zh
马里奥·内格里药理研究所
@zh-hans
type
label
Istituto di ricerche farmacologiche "Mario Negri"
@it
Mario Negri Institute for Pharmacological Research
@en
Mario Negri Institute for Pharmacological Research
@fr
Mario Negri Institute for Pharmacological Research
@nl
馬里奧內格里藥理研究所
@zh-hant
马里奥·内格里药理研究所
@zh
马里奥·内格里药理研究所
@zh-hans
altLabel
Instituto di Ricerche Farmacologiche Mario Negri
@it
Istituto di ricerche farmacologiche Mario Negri
@en
marionegri.it
@en
prefLabel
Istituto di ricerche farmacologiche "Mario Negri"
@it
Mario Negri Institute for Pharmacological Research
@en
Mario Negri Institute for Pharmacological Research
@fr
Mario Negri Institute for Pharmacological Research
@nl
馬里奧內格里藥理研究所
@zh-hant
马里奥·内格里药理研究所
@zh
马里奥·内格里药理研究所
@zh-hans
P213
P214
P244
P6366
P131
P1315
P138
P17
P213
0000 0001 0667 8902
0000 0004 0441 493X
0000 0004 1758 0021
P214
P2427
grid.4527.4
P244
P31
P3417
Mario-Negri-Institute-for-Pharmacological-Research
P3608
IT03254210150
P571
1961-01-01T00:00:00Z
P5785
P6366
P6782
P7859
lccn-n50049362